242 related articles for article (PubMed ID: 16647340)
1. Transgenic introduction of androgen receptor into estrogen-receptor-, progesterone-receptor-, and androgen-receptor-negative breast cancer cells renders them responsive to hormonal manipulation.
Garreau JR; Muller P; Pommier R; Pommier S
Am J Surg; 2006 May; 191(5):576-80. PubMed ID: 16647340
[TBL] [Abstract][Full Text] [Related]
2. A new hormonal therapy for estrogen receptor-negative breast cancer.
Hardin C; Pommier R; Calhoun K; Muller P; Jackson T; Pommier S
World J Surg; 2007 May; 31(5):1041-6. PubMed ID: 17429562
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.
Latil A; Bièche I; Vidaud D; Lidereau R; Berthon P; Cussenot O; Vidaud M
Cancer Res; 2001 Mar; 61(5):1919-26. PubMed ID: 11280747
[TBL] [Abstract][Full Text] [Related]
4. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
5. Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.
Buchanan G; Birrell SN; Peters AA; Bianco-Miotto T; Ramsay K; Cops EJ; Yang M; Harris JM; Simila HA; Moore NL; Bentel JM; Ricciardelli C; Horsfall DJ; Butler LM; Tilley WD
Cancer Res; 2005 Sep; 65(18):8487-96. PubMed ID: 16166329
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and androgen receptors as comediators of breast cancer cell proliferation: providing a new therapeutic tool.
Toth-Fejel S; Cheek J; Calhoun K; Muller P; Pommier RF
Arch Surg; 2004 Jan; 139(1):50-4. PubMed ID: 14718276
[TBL] [Abstract][Full Text] [Related]
7. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor-beta expression in human testicular germ cell tumors.
Pais V; Leav I; Lau KM; Jiang Z; Ho SM
Clin Cancer Res; 2003 Oct; 9(12):4475-82. PubMed ID: 14555521
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.
Peters AA; Buchanan G; Ricciardelli C; Bianco-Miotto T; Centenera MM; Harris JM; Jindal S; Segara D; Jia L; Moore NL; Henshall SM; Birrell SN; Coetzee GA; Sutherland RL; Butler LM; Tilley WD
Cancer Res; 2009 Aug; 69(15):6131-40. PubMed ID: 19638585
[TBL] [Abstract][Full Text] [Related]
10. Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer.
Lai J; Myers SA; Lawrence MG; Odorico DM; Clements JA
Mol Cancer Res; 2009 Jan; 7(1):129-41. PubMed ID: 19147544
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer.
Jin R; Bay BH; Chow VT; Tan PH; Lin VC
Br J Cancer; 2000 Aug; 83(3):319-23. PubMed ID: 10917545
[TBL] [Abstract][Full Text] [Related]
12. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC
Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor status in female breast cancer: RT-PCR and Western blot studies.
Bryś M; Wójcik M; Romanowicz-Makowska H; Krajewska WM
J Cancer Res Clin Oncol; 2002 Feb; 128(2):85-90. PubMed ID: 11862478
[TBL] [Abstract][Full Text] [Related]
14. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).
Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J
Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory.
Nahleh Z
Future Oncol; 2008 Feb; 4(1):15-21. PubMed ID: 18240997
[TBL] [Abstract][Full Text] [Related]
16. Selective regulation of steroid receptor expression in MCF-7 breast cancer cells by a novel member of the heregulin family.
Mueller H; Kueng W; Schoumacher F; Herzer S; Eppenberger U
Biochem Biophys Res Commun; 1995 Dec; 217(3):1271-8. PubMed ID: 8554586
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of aromatase and estrogen, androgen and progesterone receptors in normal and neoplastic human meningeal cells.
Leães CG; Meurer RT; Coutinho LB; Ferreira NP; Pereira-Lima JF; da Costa Oliveira M
Neuropathology; 2010 Feb; 30(1):44-9. PubMed ID: 19703265
[TBL] [Abstract][Full Text] [Related]
18. Progesterone, glucocorticoid, but not estrogen receptor mRNA is altered in breast cancer stroma.
Smith RA; Lea RA; Weinstein SR; Griffiths LR
Cancer Lett; 2007 Sep; 255(1):77-84. PubMed ID: 17512111
[TBL] [Abstract][Full Text] [Related]
19. The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.
Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ
Cancer; 2006 Jun; 106(12):2576-82. PubMed ID: 16703595
[TBL] [Abstract][Full Text] [Related]
20. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen.
Doane AS; Danso M; Lal P; Donaton M; Zhang L; Hudis C; Gerald WL
Oncogene; 2006 Jun; 25(28):3994-4008. PubMed ID: 16491124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
